Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

This study is currently recruiting participants.

Verified February 2013 by H. Lee Moffitt Cancer Center and Research Institute

Study NCT01581307 Information provided by H. Lee Moffitt Cancer Center and Research Institute

First Received on April 18, 2012. Last Updated on February 13, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Liver Cancer
Pancreatic Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

TheraSpheres

Additional drug interventions recognized in this trial

Fluorouracil
Folic Acid
Leucovorin
Levoleucovorin
Oxaliplatin

More general drug interventions related to this trial

Sponsors listed in this trial